In a 29‑year‑old man exposed to a whitish, grass‑smelling inhalational toxin causing tachycardia, tachypnea, hypertension and normal oxygen saturation, what is the most appropriate initial management?

Immediate Admission for Observation and Antidotal Treatment

This patient requires immediate hospital admission for observation and aggressive atropine therapy; the clinical presentation—whitish smoke with a grass-like odor following an explosion, combined with tachycardia, tachypnea, and hypertension—is pathognomonic for nerve agent (organophosphate) exposure, and brief observation followed by discharge is contraindicated.

Clinical Recognition of Nerve Agent Exposure

The constellation of findings strongly suggests nerve agent intoxication:

• The "grass-like" odor is a classic descriptor for organophosphate nerve agents such as sarin or tabun, which are weaponized cholinesterase inhibitors used in combat zones. 1
• Whitish smoke from an explosion in a combat setting is consistent with aerosolized chemical weapon deployment. 1
• Tachycardia (125 bpm), tachypnea (28/min), and hypertension (150/90) reflect early sympathetic overstimulation and anxiety, which precede the classic muscarinic signs (miosis, bronchorrhea, bradycardia) that develop as cholinergic toxicity progresses. 1
• Normal oxygen saturation (97%) at presentation does not exclude severe nerve agent poisoning; respiratory failure and bronchospasm typically evolve over hours as acetylcholine accumulates. 1

Why Brief Observation and Discharge Is Dangerous

• Nerve agent toxicity is biphasic: initial mild symptoms (cough, discomfort, tachycardia) can rapidly progress to life-threatening bronchorrhea, bronchospasm, seizures, and respiratory failure within hours. 1
• A 3-hour observation period is insufficient to exclude delayed deterioration; patients require continuous monitoring for at least 24 hours to detect evolving cholinergic crisis. 1
• Miosis (pupil constriction to ≤3 mm) is a sensitive marker of nerve agent exposure but may not appear immediately; its absence at presentation does not rule out significant exposure. 1

Immediate Management Protocol

Antidotal Therapy

• Administer atropine 2–6 mg IV immediately and repeat every 5–10 minutes until secretions dry and bronchospasm resolves; large cumulative doses (20–50 mg or more) are often required. 1
• Do not withhold atropine while awaiting laboratory confirmation (red blood cell acetylcholinesterase levels); clinical diagnosis based on history and physical findings is sufficient to initiate treatment. 1
• Pralidoxime (2-PAM) 1–2 g IV over 20–30 minutes should be given as soon as possible to reactivate acetylcholinesterase before irreversible "aging" occurs (within hours for sarin, minutes for soman). 1

Airway and Respiratory Support

• Preventing or treating respiratory insufficiency is the most crucial step toward salvaging the intoxicated patient; however, it is unwise to withhold antidotal treatment until proper oxygenation is assured. 1
• Benzodiazepines (e.g., diazepam 5–10 mg IV) are the drugs of choice to control seizures and facilitate intubation if needed. 1
• Prepare for rapid-sequence intubation if the patient develops copious secretions, bronchospasm, or altered mental status; awake intubation or rapid-sequence induction with the Sellick maneuver are the safest techniques. 1
• Suction the airway frequently to remove excessive secretions; oro- or nasopharyngeal airways can facilitate secretion removal before intubation. 1

Monitoring and Supportive Care

• Admit to a monitored bed (ICU or step-down unit) for continuous cardiorespiratory monitoring, serial vital signs, and neurologic assessments. 1
• Fluid resuscitation may be required if hypotension develops from vasodilation or fluid losses (vomiting, diarrhea); dopamine or epinephrine are preferred over norepinephrine because their tachycardic effects counteract nerve agent-induced bradycardia. 1
• Reassess every 15–30 minutes for signs of deterioration: worsening secretions, miosis, fasciculations, altered mental status, or respiratory distress. 1

Why Other Options Are Incorrect

• Intravenous antibiotics have no role in nerve agent poisoning; this is a toxicologic emergency, not an infectious process. 1
• Nebulized N-acetylcysteine is a mucolytic used for acetaminophen overdose or thick secretions in chronic lung disease; it does not antagonize cholinergic toxicity and will not prevent respiratory failure from nerve agents. 1
• Observing for 3 hours then discharging is contraindicated because nerve agent toxicity can progress insidiously over 6–24 hours; patients who appear stable initially may deteriorate rapidly once they leave the hospital. 1

Critical Pitfalls to Avoid

• Do not delay atropine administration while attempting to confirm the diagnosis with laboratory tests; clinical suspicion in a combat zone is sufficient. 1
• Do not underdose atropine; the goal is complete drying of secretions and resolution of bronchospasm, which may require cumulative doses exceeding 50 mg. 1
• Do not assume normal oxygen saturation excludes severe poisoning; hypoxia is a late finding that signals impending respiratory arrest. 1
• Do not discharge the patient after brief observation; nerve agent casualties require at least 24 hours of inpatient monitoring to detect delayed deterioration. 1